Kenneth Bender, PharmD, MA

The addition of ribavirin to direct-acting antiviral treatment of HCV with cryoglobulinemia aided to achieving immunological response.

HCV heightens the risk for kidney disease but, the disease's treatment improves rates of survival in patients on hemodialysis.

A higher prevalence of HCV in adults who received surgery for congenital heart disease as children is a "double whammy" when procedures leaves systemic venous congestion affecting hepatic veins, researchers said.

Eight weeks of ledipasvir and sofosbuvir for HCV genotype 1 was found as effective as 12 weeks in patients of different race and ethnicity despite guidelines recommending the shorter treatment for non-black patients.

A component in inflammatory pathogenesis including airway inflammation could serve as a biomarker in non-eosinophilic asthma.

The approved use of a direct-acting antiviral combination for 8 weeks to treat HCV genotypes 1 and 3 was supported by data from over 1200 patients.

Although the causes of MS remain unknown, a variety of factors have been linked to exacerbations and relapse—and several that have recently been associated with increased risk of onset are avoidable.

Although the factor Xa (FXa) inhibitor oral anticoagulants have fewer drug interactions and are without burdens associated with warfarin, such as blood test monitoring, dosage adjustment, and diet restriction, they also lack an approved antidote to their anticoagulant effect.

The anti-inflammatory proved superior to as-need bronchodilator for control of early stage asthma symptoms in preschool children.

A newly discovered hepatitis C virus (HCV) subtype harbors resistance-associated mutations to direct acting antivirals.

Psychological stress-induced alterations of the neuroendocrine-immune system in allergic airway inflammation suggest a novel phenotype in asthma.

Treatment of HCV was associated with lower risk for other maladies in the largest western study of the relationship between antiviral treatment and extrahepatic conditions.

A video game-like interactive program evidences promise in proof-of-concept study prior to FDA review as a medical device to treat children with ADHD.

Direct-acting antiviral agent treatment of HCV was well tolerated and appeared synergistic with chemotherapy of comorbid non-Hodgkin's lymphoma.

The addition of guanfacine to a psychostimulant improved executive function in children with ADHD.

A newly developed Environmental Scoring System proves useful in disparate home-based asthma intervention programs.

Review corroborates sports medicine findings that athletes with ADHD are at risk for increased cognitive dysfunction and prolonged recovery from concussions.

Increased prevalence of HCV infection among hospitalized children is linked to increase in substance abuse

A meta-analysis found methylphenidate treatment of children with ADHD improves academic productivity more than accuracy, effecting performance in math more than reading.

HCV reactivation can occur during treatment of non-hepatic cancer, increasing risk of hepatic injury and interfering with cancer treatment.

Treating adults with ADHD challenges clinicians to overcome associated stigma, complexity and controversy to help patients overcome this hidden disability.

The CDC attributes up to 21% of US asthma deaths to occupational exposures, and considers many potentially avoidable.

Two doses of dexamethasone resulted in similar outcomes with better adherence than five days of prednisone in children with acute asthma.